PUR Biologics
Developer and supplier of orthopedic and spinal biologic materials and regenerative therapeutics. Organizes products and development across four categories—advanced allografts, specialized synthetics, cellular-derived therapies, and amniotic-derived extracellular matrix—targeting bone, cartilage and spinal disc repair.
Industries
Nr. of Employees
small (1-50)
PUR Biologics
Irvine, California, United States, North America
Products
Allograft bone grafts and chips
Bone-derived allograft formats intended for bone repair and spinal fusion procedures.
Synthetic scaffold and bone substitute materials
Synthetic structural implants and particulate substitutes for bone regeneration and spinal support.
Cell-based regenerative products
Marrow-derived and other cellular preparations intended to support tissue regeneration in orthopedic applications.
Amniotic-derived extracellular matrix materials
ECM products derived from amniotic tissue for soft-tissue and regenerative indications.
Allograft bone grafts and chips
Bone-derived allograft formats intended for bone repair and spinal fusion procedures.
Synthetic scaffold and bone substitute materials
Synthetic structural implants and particulate substitutes for bone regeneration and spinal support.
Cell-based regenerative products
Marrow-derived and other cellular preparations intended to support tissue regeneration in orthopedic applications.
Amniotic-derived extracellular matrix materials
ECM products derived from amniotic tissue for soft-tissue and regenerative indications.
Services
Provision and fulfillment of bone allograft materials and bone chips for surgical use.
Provision of specialized synthetic scaffolds and bone graft substitute materials for structural and fusion applications.
Supply of marrow-derived and other cell-based regenerative products for orthopaedic use.
Provision of amniotic-derived extracellular matrix materials for regenerative and soft-tissue applications.
Provision and fulfillment of bone allograft materials and bone chips for surgical use.
Provision of specialized synthetic scaffolds and bone graft substitute materials for structural and fusion applications.
Supply of marrow-derived and other cell-based regenerative products for orthopaedic use.
Provision of amniotic-derived extracellular matrix materials for regenerative and soft-tissue applications.
Expertise Areas
- Orthopedic and spinal biologics
- Regenerative medicine
- Allograft processing and supply
- Synthetic bone graft development
Key Technologies
- Allograft processing
- Synthetic bone graft scaffolds
- Cellular orthobiologics
- Amniotic-derived extracellular matrix (ECM)
News & Updates
Company describes its regenerative biologics activity as ongoing since 2018.
Operates as a subsidiary or business unit of a publicly traded healthcare/biotechnology company; affiliation and parent company headquarters information are presented on the site.
Company describes its regenerative biologics activity as ongoing since 2018.
Operates as a subsidiary or business unit of a publicly traded healthcare/biotechnology company; affiliation and parent company headquarters information are presented on the site.